Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$253.77
-11.71-4.41%
At close: -
$254.00
0.230.09%
After Hours: Apr 4, 5:55 PM EDT
Comments
Loading...
Humana Analyst Ratings and Price Targets | NYSE:HUM | Benzinga
Humana Inc has a consensus price target of $309.32 based on the ratings of 25 analysts. The high is $624 issued by Morgan Stanley on August 30, 2023. The low is $250 issued by Stephens & Co. on October 9, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Barclays, and RBC Capital on February 18, 2025, February 13, 2025, and February 12, 2025, respectively. With an average price target of $269.67 between JP Morgan, Barclays, and RBC Capital, there's an implied 6.17% upside for Humana Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Barclays
RBC Capital
Cantor Fitzgerald
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Humana
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/18/2025 | Buy Now | 0.79% | JP Morgan | Lisa Gill60% | $257 → $256 | Maintains | Neutral | Get Alert |
| 02/13/2025 | Buy Now | 6.3% | Barclays | Andrew Mok57% | $255 → $270 | Maintains | Equal-Weight | Get Alert |
| 02/12/2025 | Buy Now | 11.42% | RBC Capital | Ben Hendrix61% | $283 → $283 | Reiterates | Outperform → Outperform | Get Alert |
| 02/12/2025 | Buy Now | 14.17% | Cantor Fitzgerald | Sarah James52% | $290 → $290 | Reiterates | Neutral → Neutral | Get Alert |
| 02/12/2025 | Buy Now | 12.2% | Morgan Stanley | Erin Wright76% | $301 → $285 | Maintains | Equal-Weight | Get Alert |
| 01/22/2025 | Buy Now | 0.39% | Barclays | Andrew Mok57% | $253 → $255 | Maintains | Equal-Weight | Get Alert |
| 01/15/2025 | Buy Now | 13.39% | Piper Sandler | Jessica Tassan41% | $270 → $288 | Maintains | Neutral | Get Alert |
| 01/06/2025 | Buy Now | 14.17% | Truist Securities | David Macdonald68% | $260 → $290 | Maintains | Hold | Get Alert |
| 12/17/2024 | Buy Now | 18.5% | Morgan Stanley | Erin Wright76% | $288 → $301 | Maintains | Equal-Weight | Get Alert |
| 11/06/2024 | Buy Now | 21.26% | B of A Securities | Kevin Fischbeck67% | $247 → $308 | Upgrade | Underperform → Neutral | Get Alert |
| 11/04/2024 | Buy Now | 5.51% | TD Cowen | Gary Taylor60% | $261 → $268 | Maintains | Hold | Get Alert |
| 11/04/2024 | Buy Now | 14.17% | Wells Fargo | Stephen Baxter56% | $387 → $290 | Maintains | Overweight | Get Alert |
| 10/31/2024 | Buy Now | -0.39% | Barclays | Andrew Mok57% | $250 → $253 | Maintains | Equal-Weight | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor65% | — | Initiates | → Sector Weight | Get Alert |
| 10/11/2024 | Buy Now | 2.36% | Truist Securities | David Macdonald68% | $400 → $260 | Maintains | Hold | Get Alert |
| 10/10/2024 | Buy Now | -1.57% | Barclays | Andrew Mok57% | $364 → $250 | Maintains | Equal-Weight | Get Alert |
| 10/09/2024 | Buy Now | -1.57% | Stephens & Co. | Scott Fidel69% | $250 → $250 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 10/08/2024 | Buy Now | 21.26% | Bernstein | Lance Wilkes62% | → $308 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/08/2024 | Buy Now | 4.33% | RBC Capital | Ben Hendrix61% | $400 → $265 | Maintains | Outperform | Get Alert |
| 10/07/2024 | Buy Now | 2.76% | TD Cowen | Gary Taylor60% | $402 → $261 | Downgrade | Buy → Hold | Get Alert |
| 10/07/2024 | Buy Now | -0.39% | Jefferies | David Windley74% | $419 → $253 | Downgrade | Buy → Hold | Get Alert |
| 10/04/2024 | Buy Now | -1.57% | UBS | Kevin Caliendo72% | $380 → $250 | Maintains | Neutral | Get Alert |
| 10/03/2024 | Buy Now | 7.87% | Piper Sandler | Jessica Tassan41% | $392 → $274 | Downgrade | Overweight → Neutral | Get Alert |
| 10/03/2024 | Buy Now | -1.57% | Deutsche Bank | George Hill62% | $349 → $250 | Maintains | Hold | Get Alert |
| 10/03/2024 | Buy Now | 10.24% | Oppenheimer | Michael Wiederhorn61% | $400 → $280 | Maintains | Outperform | Get Alert |
| 10/02/2024 | Buy Now | -2.76% | B of A Securities | Kevin Fischbeck67% | $376 → $247 | Downgrade | Neutral → Underperform | Get Alert |
| 10/02/2024 | Buy Now | -1.57% | Stephens & Co. | Scott Fidel69% | $400 → $250 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/02/2024 | Buy Now | -1.57% | Leerink Partners | Whit Mayo68% | $400 → $250 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/01/2024 | Buy Now | 55.51% | Cantor Fitzgerald | Sarah James52% | $395 → $395 | Reiterates | Neutral → Neutral | Get Alert |
| 09/20/2024 | Buy Now | 55.51% | Cantor Fitzgerald | Sarah James52% | $395 → $395 | Reiterates | Neutral → Neutral | Get Alert |
| 09/10/2024 | Buy Now | 55.51% | Cantor Fitzgerald | Sarah James52% | $395 → $395 | Reiterates | Neutral → Neutral | Get Alert |
| 09/05/2024 | Buy Now | 57.48% | RBC Capital | Ben Hendrix61% | $385 → $400 | Maintains | Outperform | Get Alert |
| 08/21/2024 | Buy Now | 55.91% | JP Morgan | Lisa Gill60% | $332 → $396 | Maintains | Neutral | Get Alert |
| 08/19/2024 | Buy Now | 55.51% | Cantor Fitzgerald | Sarah James52% | $395 → $395 | Reiterates | Neutral → Neutral | Get Alert |
| 08/02/2024 | Buy Now | 37.4% | Deutsche Bank | George Hill62% | $341 → $349 | Maintains | Hold | Get Alert |
| 08/01/2024 | Buy Now | 43.31% | Barclays | Andrew Mok57% | $370 → $364 | Maintains | Equal-Weight | Get Alert |
| 08/01/2024 | Buy Now | 57.48% | Oppenheimer | Michael Wiederhorn61% | $370 → $400 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | 60.24% | TD Cowen | Gary Taylor60% | $396 → $407 | Maintains | Buy | Get Alert |
| 07/23/2024 | Buy Now | 41.73% | Cantor Fitzgerald | Sarah James52% | $360 → $360 | Reiterates | Neutral → Neutral | Get Alert |
| 07/15/2024 | Buy Now | 57.48% | Truist Securities | David Macdonald68% | $355 → $400 | Maintains | Hold | Get Alert |
| 06/26/2024 | Buy Now | 54.33% | Piper Sandler | Jessica Tassan41% | → $392 | Initiates | → Overweight | Get Alert |
| 06/24/2024 | Buy Now | 47.24% | Morgan Stanley | Erin Wright76% | → $374 | Initiates | → Equal-Weight | Get Alert |
| 06/12/2024 | Buy Now | 41.73% | Cantor Fitzgerald | Sarah James52% | $360 → $360 | Reiterates | Neutral → Neutral | Get Alert |
| 05/30/2024 | Buy Now | 47.24% | Baird | Michael Ha52% | → $374 | Initiates | → Neutral | Get Alert |
| 05/20/2024 | Buy Now | 48.03% | B of A Securities | Kevin Fischbeck67% | $342 → $376 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | 38.98% | RBC Capital | Frank Morgan45% | $415 → $353 | Maintains | Outperform | Get Alert |
| 04/25/2024 | Buy Now | 28.35% | UBS | Kevin Caliendo72% | $334 → $326 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | 41.73% | Cantor Fitzgerald | Sarah James52% | $391 → $360 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | 45.67% | Oppenheimer | Michael Wiederhorn61% | $415 → $370 | Maintains | Outperform | Get Alert |
| 04/22/2024 | Buy Now | 50% | Jefferies | David Windley74% | $411 → $381 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 53.94% | Cantor Fitzgerald | Sarah James52% | $391 → $391 | Reiterates | Neutral → Neutral | Get Alert |
| 04/08/2024 | Buy Now | 37.8% | Wells Fargo | Stephen Baxter56% | $413 → $350 | Maintains | Overweight | Get Alert |
| 04/04/2024 | Buy Now | 53.94% | Cantor Fitzgerald | Sarah James52% | $391 → $391 | Reiterates | Neutral → Neutral | Get Alert |
| 04/03/2024 | Buy Now | 51.57% | Goldman Sachs | Nathan Rich43% | $450 → $385 | Maintains | Buy | Get Alert |
| 04/02/2024 | Buy Now | 22.05% | Barclays | Andrew Mok57% | $356 → $310 | Maintains | Equal-Weight | Get Alert |
| 04/02/2024 | Buy Now | 55.91% | TD Cowen | Gary Taylor60% | $427 → $396 | Maintains | Buy | Get Alert |
| 04/02/2024 | Buy Now | 34.65% | B of A Securities | Kevin Fischbeck67% | $470 → $342 | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2024 | Buy Now | — | Raymond James | John Ransom76% | — | Initiates | → Market Perform | Get Alert |
| 03/13/2024 | Buy Now | — | Argus Research | David Toung72% | — | Downgrade | Buy → Hold | Get Alert |
| 03/06/2024 | Buy Now | 40.16% | Barclays | Andrew Mok57% | → $356 | Initiates | → Equal-Weight | Get Alert |
| 01/30/2024 | Buy Now | 62.6% | Wells Fargo | Stephen Baxter56% | $465 → $413 | Maintains | Overweight | Get Alert |
| 01/29/2024 | Buy Now | 77.17% | Goldman Sachs | Nathan Rich43% | $515 → $450 | Maintains | Buy | Get Alert |
| 01/26/2024 | Buy Now | 69.29% | Stephens & Co. | Scott Fidel69% | $550 → $430 | Maintains | Overweight | Get Alert |
| 01/26/2024 | Buy Now | 57.48% | Mizuho | Ann Hynes86% | $550 → $400 | Maintains | Buy | Get Alert |
| 01/26/2024 | Buy Now | 53.94% | Cantor Fitzgerald | Sarah James52% | $597 → $391 | Downgrade | Overweight → Neutral | Get Alert |
| 01/26/2024 | Buy Now | 45.67% | UBS | Kevin Caliendo72% | $530 → $370 | Downgrade | Buy → Neutral | Get Alert |
| 01/26/2024 | Buy Now | 63.39% | RBC Capital | Ben Hendrix61% | $507 → $415 | Maintains | Outperform | Get Alert |
| 01/26/2024 | Buy Now | 77.17% | Goldman Sachs | Nathan Rich43% | $515 → $450 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | 41.73% | Deutsche Bank | George Hill62% | $595 → $360 | Downgrade | Buy → Hold | Get Alert |
| 01/19/2024 | Buy Now | 135.04% | Cantor Fitzgerald | Sarah James52% | $597 → $597 | Reiterates | Overweight → Overweight | Get Alert |
| 01/19/2024 | Buy Now | 116.54% | Truist Securities | David Macdonald68% | → $550 | Reiterates | Hold → Hold | Get Alert |
| 01/19/2024 | Buy Now | 99.61% | RBC Capital | Ben Hendrix61% | $599 → $507 | Maintains | Outperform | Get Alert |
| 01/19/2024 | Buy Now | 102.76% | Goldman Sachs | Nathan Rich43% | $595 → $515 | Maintains | Buy | Get Alert |
| 01/17/2024 | Buy Now | 148.03% | Oppenheimer | Michael Wiederhorn61% | → $630 | Reiterates | Outperform → Outperform | Get Alert |
| 12/12/2023 | Buy Now | 116.54% | Argus Research | David Toung72% | → $550 | Upgrade | Hold → Buy | Get Alert |
| 11/21/2023 | Buy Now | 135.04% | Cantor Fitzgerald | Sarah James52% | → $597 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 126.38% | JP Morgan | Lisa Gill60% | $593 → $575 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | 135.83% | RBC Capital | Ben Hendrix61% | $594 → $599 | Maintains | Outperform | Get Alert |
| 11/02/2023 | Buy Now | 124.41% | Stephens & Co. | Scott Fidel69% | $575 → $570 | Maintains | Overweight | Get Alert |
| 11/02/2023 | Buy Now | 135.04% | Cantor Fitzgerald | Sarah James52% | → $597 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | Buy Now | 130.71% | Jefferies | David Windley74% | $580 → $586 | Maintains | Buy | Get Alert |
| 09/14/2023 | Buy Now | 135.04% | Cantor Fitzgerald | Sarah James52% | → $597 | Reiterates | Overweight → Overweight | Get Alert |
| 08/30/2023 | Buy Now | 145.67% | Morgan Stanley | Michael Ha52% | $637 → $624 | Maintains | Overweight | Get Alert |
| 08/15/2023 | Buy Now | 141.34% | TD Cowen | Gary Taylor60% | $616 → $613 | Maintains | Outperform | Get Alert |
| 08/08/2023 | Buy Now | 135.83% | Bernstein | Lance Wilkes62% | $568 → $599 | Maintains | Market Perform | Get Alert |
| 08/07/2023 | Buy Now | 147.24% | Deutsche Bank | George Hill62% | $468 → $628 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 116.54% | Truist Securities | David Macdonald68% | $530 → $550 | Maintains | Hold | Get Alert |
| 08/03/2023 | Buy Now | 133.86% | RBC Capital | Ben Hendrix61% | $637 → $594 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 120.47% | Stephens & Co. | Scott Fidel69% | $555 → $560 | Maintains | Overweight | Get Alert |
| 07/14/2023 | Buy Now | 150.79% | Morgan Stanley | Michael Ha52% | $637 → $637 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | Buy Now | 120.47% | UBS | Kevin Caliendo72% | $620 → $560 | Maintains | Buy | Get Alert |
| 07/13/2023 | Buy Now | 112.99% | Wells Fargo | Stephen Baxter56% | $610 → $541 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 116.54% | Mizuho | Ann Hynes86% | $615 → $550 | Maintains | Buy | Get Alert |
| 07/07/2023 | Buy Now | 112.6% | JP Morgan | Lisa Gill60% | $576 → $540 | Downgrade | Overweight → Neutral | Get Alert |
| 06/23/2023 | Buy Now | — | Argus Research | David Toung72% | — | Downgrade | Buy → Hold | Get Alert |
| 06/20/2023 | Buy Now | 108.66% | Truist Securities | David Macdonald68% | $590 → $530 | Maintains | Hold | Get Alert |
| 06/20/2023 | Buy Now | 150.79% | RBC Capital | Ben Hendrix61% | → $637 | Reiterates | Outperform → Outperform | Get Alert |
| 06/15/2023 | Buy Now | 150.79% | RBC Capital | Ben Hendrix61% | → $637 | Reiterates | Outperform → Outperform | Get Alert |
| 05/30/2023 | Buy Now | 126.77% | JP Morgan | Lisa Gill60% | $625 → $576 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 142.52% | TD Cowen | Gary Taylor60% | $581 → $616 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Humana (HUM) stock?
The latest price target for Humana (NYSE:HUM) was reported by JP Morgan on February 18, 2025. The analyst firm set a price target for $256.00 expecting HUM to rise to within 12 months (a possible 0.79% upside). 52 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Humana (HUM)?
The latest analyst rating for Humana (NYSE:HUM) was provided by JP Morgan, and Humana maintained their neutral rating.
When was the last upgrade for Humana (HUM)?
The last upgrade for Humana Inc happened on November 6, 2024 when B of A Securities raised their price target to $308. B of A Securities previously had an underperform for Humana Inc.
When was the last downgrade for Humana (HUM)?
The last downgrade for Humana Inc happened on October 7, 2024 when TD Cowen changed their price target from $402 to $261 for Humana Inc.
When is the next analyst rating going to be posted or updated for Humana (HUM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humana was filed on February 18, 2025 so you should expect the next rating to be made available sometime around February 18, 2026.
Is the Analyst Rating Humana (HUM) correct?
While ratings are subjective and will change, the latest Humana (HUM) rating was a maintained with a price target of $257.00 to $256.00. The current price Humana (HUM) is trading at is $254.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.